Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China flag China · Delayed Price · Currency is CNY
5.89
+0.26 (4.62%)
Aug 20, 2026, 3:04 PM CST

SHE:300039 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
259.16278.58375.58327.87190.8140.11
Depreciation & Amortization
33.4933.4936.0537.5331.7133.86
Other Amortization
2.192.190.290.110.01-
Loss (Gain) From Sale of Assets
-0.04-0.040.260.210.170.22
Asset Writedown & Restructuring Costs
8.828.82-3.037.330.65-6.16
Loss (Gain) From Sale of Investments
-18.86-18.86-11.43-4.9210.694.85
Other Operating Activities
-21.92-0.31-0.43-1.64-0.44-0.68
Change in Accounts Receivable
23.423.4-0.1499.5358.32-74.9
Change in Inventory
-12.73-12.73-16.26-10.334.0627.22
Change in Accounts Payable
-84.92-84.92-102.8-60.1876.9-4.37
Change in Other Net Operating Assets
-1.62-1.62-4.32-5.336.83.33
Operating Cash Flow
189.7230.74278.95382.66376.42126.08
Operating Cash Flow Growth
-35.64%-17.28%-27.10%1.66%198.56%-49.70%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-23.46-27.04-140.52-29.08-31.62-42.55
Sale of Property, Plant & Equipment
0.520.510.030.030.270.15
Cash Acquisitions
------14.52
Investment in Securities
-6.87227.8790.73-181.21-257.11-29.93
Other Investing Activities
75.6790.216.3311.633.083.34
Investing Cash Flow
45.86291.54-33.43-198.63-285.37-83.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-1.325.42---
Total Debt Issued
1.321.325.42---
Short-Term Debt Repaid
--0.24----
Long-Term Debt Repaid
------37.72
Total Debt Repaid
-0.24-0.24----37.72
Net Debt Issued (Repaid)
1.091.095.42---37.72
Common Dividends Paid
-136.03-136.03-104.6-62.76-52.3-31.64
Other Financing Activities
0.02--0.05---
Financing Cash Flow
-134.92-134.95-99.23-62.76-52.3-69.37

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash Flow
100.64387.34146.3121.2738.75-26.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
166.25203.7138.43353.59344.883.53
Free Cash Flow Growth
11.03%47.16%-60.85%2.55%312.79%-64.71%
Free Cash Flow Margin
16.06%17.67%9.40%22.18%30.82%7.59%
Free Cash Flow Per Share
0.160.200.130.340.330.08
Levered Free Cash Flow
122.56180.9415.48261.78275.0416.78
Unlevered Free Cash Flow
122.6318115.5261.78275.0416.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
--0.04---
Cash Income Tax Paid
164.31192.56239.25255.43144.47157.16
Change in Working Capital
-73.14-73.14-118.3316.17142.82-46.13